{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:26:01Z","timestamp":1778675161681,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["97009333"],"award-info":[{"award-number":["97009333"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["TP-9461"],"award-info":[{"award-number":["TP-9461"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.virusres.2021.198403","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:26:36Z","timestamp":1616783196000},"page":"198403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine"],"prefix":"10.1016","volume":"298","author":[{"given":"Mona","family":"Sadat Larijani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitis","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mashhadi Abolghasem Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Bolhassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hassan","family":"Pouriayevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mehdi","family":"Sadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"62","key":"10.1016\/j.virusres.2021.198403_bib0005","article-title":"TLR2\/MyD88 pathway-dependent regulation of dendritic cells by dengue virus promotes antibody-dependent enhancement via Th2-biased immunity","volume":"8","author":"Aleyas George","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12432","article-title":"Dendritic cell maturation and cross-presentation: timing matters!","volume":"272","author":"Alloatti","year":"2016","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.virusres.2021.198403_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2796.2006.01738.x","article-title":"A dendritic cell-based vaccine for treating HIV infection: background and preliminary results","volume":"261","author":"Andrieu","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.virusres.2021.198403_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/869718","article-title":"Targeting antigens to dendritic cell receptors for vaccine development","volume":"2013","author":"Apostolopoulos","year":"2013","journal-title":"J. Drug Deliv."},{"issue":"4","key":"10.1016\/j.virusres.2021.198403_bib0025","first-page":"268","article-title":"Effects of dendritic cell vaccine activated with components of lieshmania major on tumor specific response","volume":"16","author":"Arab","year":"2019","journal-title":"Iran. J. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41541-018-0086-0","article-title":"Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates","volume":"3","author":"Bayon","year":"2018","journal-title":"Npj Vaccines"},{"issue":"70","key":"10.1016\/j.virusres.2021.198403_bib0035","article-title":"The dendritic cell synapse: a life dedicated to t cell activation","volume":"7","author":"Benvenuti","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0040","first-page":"17","article-title":"An optimized method for ex vivo generation of dendritic cells","volume":"69","author":"Bonab","year":"2014","journal-title":"J. Vet. Res."},{"issue":"5","key":"10.1016\/j.virusres.2021.198403_bib0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/mt.2011.57","article-title":"Engineering dendritic cells to enhance cancer immunotherapy","volume":"19","author":"Boudreau","year":"2011","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.virusres.2021.198403_bib0050","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jid.2016.01.033","article-title":"Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1","volume":"136","author":"Caucheteux","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.virusres.2021.198403_bib0055","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1128\/JVI.02725-06","article-title":"Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor","volume":"81","author":"Chaudhuri","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198403_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-391858-1.00008-3","article-title":"Targeting nanoparticles to dendritic cells for immunotherapy","volume":"509","author":"Cruz","year":"2012","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.virusres.2021.198403_bib0065","first-page":"47","article-title":"Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo","author":"Dai","year":"2015","journal-title":"Acta. Biochim. Biophys. Sin."},{"issue":"9","key":"10.1016\/j.virusres.2021.198403_bib0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/cancers11091396","article-title":"Dendritic cell-based and other vaccination strategies for pediatric Cancer","volume":"11","author":"de Bruijn","year":"2019","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.virusres.2021.198403_bib0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits t cell responses associated with control of HIV-1 replication","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"38","key":"10.1016\/j.virusres.2021.198403_bib0080","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2011.07.043","article-title":"Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1","volume":"29","author":"Garc\u00eda","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2021.198403_bib0085","series-title":"Global H.I.V. & AIDS Statistics","year":"2020"},{"issue":"2804","key":"10.1016\/j.virusres.2021.198403_bib0090","article-title":"Current state of dendritic cell-based immunotherapy: opportunities for in vitro antigen loading of different DC Subsets?","volume":"9","author":"Huber","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2021.198403_bib0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.13.22","article-title":"Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies","volume":"12","author":"Kalinski","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0100","first-page":"206","article-title":"Differentiation, maturation, and survival of dendritic cells by osteopontin regulation","volume":"12","author":"Kawamura","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20050566","article-title":"Dendritic cells star in Vancouver","volume":"202","author":"Klechevsky","year":"2005","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.virusres.2021.198403_bib0110","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/JVI.80.7.3128-3134.2006","article-title":"Toll-like receptor-independent triggering of dendritic cell maturation by viruses","volume":"80","author":"L\u00f3pez","year":"2006","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2021.198403_bib0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/CJI.0b013e3181a1c24e","article-title":"Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function","volume":"32","author":"L\u00f3pez-Albaitero","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.virusres.2021.198403_bib0120","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6743904","article-title":"Development of monoclonal antibodies against HIV-1 p24 protein and its application in colloidal gold immunochromatographic assay for HIV-1 detection","volume":"2016","author":"Ma","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.virusres.2021.198403_bib0125","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin. Transl. Immunol."},{"issue":"766","key":"10.1016\/j.virusres.2021.198403_bib0130","article-title":"Personalized dendritic cell vaccines\u2014recent breakthroughs and encouraging clinical results","volume":"10","author":"Mastelic-Gavillet","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2021.198403_bib0135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ni.2264","article-title":"Lessons learned from HIV-1 vaccine trials: new priorities and directions","volume":"13","author":"McMichael","year":"2012","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0140","first-page":"013","article-title":"HIV-1 Immune evasion: the main obstacle toward a successful vaccine. Archives of Asthma","volume":"2","author":"Mona","year":"2018","journal-title":"Allergy Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2021.198403_bib0145","first-page":"322","article-title":"In silico design and immunologic evaluation of HIV-1 p24-Nef fusion protein to approach a therapeutic vaccine candidate","volume":"16","author":"Mona","year":"2018","journal-title":"Curr. HIV Res."},{"issue":"2","key":"10.1016\/j.virusres.2021.198403_bib0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1570162X17666190618160608","article-title":"Updated studies on the development of HIV therapeutic vaccine","volume":"17","author":"Mona","year":"2019","journal-title":"Curr. HIV Res."},{"issue":"4","key":"10.1016\/j.virusres.2021.198403_bib0155","first-page":"89","article-title":"A shot at dendritic cell-based vaccine strategy against HIV-1","volume":"7","author":"Mona","year":"2020","journal-title":"J. Med. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.virusres.2021.198403_bib0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1567201817666200317121728","article-title":"Production of recombinant HIV-1 p24-Nef protein in two forms as potential candidate vaccines in three vehicles","volume":"17","author":"Mona","year":"2020","journal-title":"Curr. Drug Deliv."},{"issue":"5\u20136","key":"10.1016\/j.virusres.2021.198403_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/08830180600992456","article-title":"Dendritic cell-based immunotherapy","volume":"25","author":"Osada","year":"2006","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.virusres.2021.198403_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbagen.2015.01.003","article-title":"HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion","volume":"1850","author":"Pawlak","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0175","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/s41467-019-13368-y","article-title":"Engineering dendritic cell vaccines to improve cancer immunotherapy","volume":"10","author":"Perez","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2021.198403_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fimmu.2015.00091","article-title":"Dendritic cell-based vaccine efficacy: aiming for hot spots","volume":"6","author":"Pizzurro","year":"2015","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.virusres.2021.198403_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tim.2004.05.003","article-title":"Virus infection of dendritic cells: portal for host invasion and host defense","volume":"12","author":"Rinaldo","year":"2004","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.virusres.2021.198403_bib0190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clim.2009.09.009","article-title":"Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy","volume":"134","author":"Routy","year":"2010","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.virusres.2021.198403_bib0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.29252\/JoMMID.7.4.89","article-title":"A shot at dendritic cell-based vaccine strategy against HIV-1","volume":"7","author":"Sadat Larijani","year":"2019","journal-title":"JoMMID."},{"issue":"2","key":"10.1016\/j.virusres.2021.198403_bib0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-emergence of dendritic cell vaccines for Cancer treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.virusres.2021.198403_bib0210","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1567201816666190923152914","article-title":"Combination of mechanical and chemical methods improves gene delivery in cell-based HIV vaccines","volume":"16","author":"Sepehr","year":"2019","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.virusres.2021.198403_bib0215","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.181.4.2455","article-title":"The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells","volume":"181","author":"Sheng","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2021.198403_bib0220","series-title":"Dendritic Cells: Important Adjuvants During DNA Vaccination: Georgetown","author":"Steinman","year":"2002"},{"issue":"3","key":"10.1016\/j.virusres.2021.198403_bib0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/biomedicines2030229","article-title":"Lentivirus-induced dendritic cells (iDC) for immune-regenerative therapies in Cancer and stem cell transplantation","volume":"2","author":"Stripecke","year":"2014","journal-title":"Biomedicines."},{"issue":"9","key":"10.1016\/j.virusres.2021.198403_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008011","article-title":"Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination","volume":"15","author":"Surenaud","year":"2019","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.virusres.2021.198403_bib0235","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/aid.2016.0168","article-title":"Conserved HIV-1 gag p24 epitopes elicit cellular immune responses that impact disease outcome","volume":"33","author":"Tarosso","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.virusres.2021.198403_bib0240","first-page":"434","article-title":"Construction and production of HIV-VLP harboring MPER-V3 for potential vaccine study","volume":"15","author":"Tohidi","year":"2017","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.virusres.2021.198403_bib0245","doi-asserted-by":"crossref","DOI":"10.2174\/1570162X17666190306124218","article-title":"Induction of a robust humoral response using HIV-1 VLPMPER-V3as a novel candidate vaccine in BALB\/c mice","author":"Tohidi","year":"2019","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.virusres.2021.198403_bib0250","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ijms19041241","article-title":"HIV vaccination: a roadmap among advancements and concerns","volume":"19","author":"Trovato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.virusres.2021.198403_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192278","article-title":"Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment","volume":"13","author":"van den Ham","year":"2018","journal-title":"PLoS One"},{"issue":"2265","key":"10.1016\/j.virusres.2021.198403_bib0260","article-title":"Dendritic cell Cancer therapy: vaccinating the right patient at the right time","volume":"9","author":"van Willigen","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2021.198403_bib0265","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.4049\/jimmunol.167.3.1283","article-title":"Multiple paths for activation of naive CD8<sup>+<\/sup> t cells: CD4-Independent help","volume":"167","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2021.198403_bib0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1743-422X-10-240","article-title":"Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways","volume":"10","author":"Wang","year":"2013","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40880-019-0387-3","article-title":"Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives","volume":"39","author":"Wang","year":"2019","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.virusres.2021.198403_bib0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226803","article-title":"Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans","volume":"15","author":"Zhao","year":"2020","journal-title":"PLoS One"},{"issue":"42","key":"10.1016\/j.virusres.2021.198403_bib0285","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0805325105","article-title":"Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines","volume":"105","author":"Zhu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:04:25Z","timestamp":1778673865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":57,"alternative-id":["S0168170221001106"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198403","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198403"}}